Savvy plaintiffs-side attorneys are leveraging this split to avoid bringing their FLSA collective action where the employer ...

Johnson & Johnson and other pharma companies aim to change how the 340B Drug Pricing Program functions. Courts must rule if ...

Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty-two cents ($0.62) per share on the $0.10 par value common stock of the company.

Novel triple-drug therapies are showing promise for patients with various kinds of leukemia, researchers reported at the ...

Keros Therapeutics has halted dosing in two of the three treatment arms of a phase 2 trial of its pulmonary arterial ...

Squibb announced that its Board of Directors has declared a quarterly dividend of 62c per share on the 10c par value common ...

Shares of Bristol Myers Squibb Co. BMY slid 1.00% to $58.12 Tuesday, on what proved to be an all-around grim trading session ...

If we earn a $0.63 per share dividend in early January, and then if BMY closes above $60 on January 17, we would be assigned ...

Analyst Evan Seigerman of BMO Capital maintained a Hold rating on Bristol-Myers Squibb (BMY – Research Report), retaining the price target of ...

The annualized dividend paid by Bristol Myers Squibb Co. is $2.4/share, currently paid in quarterly installments, and its most recent dividend ex-date was on 10/04/2024 ...

The stock's fall snapped a two-day winning streak.